The latest biotech news

hypertension treatment idorsia janssen2 1

News and Trends 4 Dec 2017

Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III

Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could help to prevent future heart attacks and strokes. Idorsia was born out of Actelion’s massive $30B (€27.9B) acquisition by Johnson & Johnson, retaining all of the former biotech’s early-stage assets. The company develops small molecules for a broad range of […]

December 4, 2017 - 3 minutesmins - By Alex Dale

News and Trends 4 Dec 2017

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors suitable for bone marrow transplant to treat blood cancer. From its Amsterdam headquarters, Kiadis Pharma is developing a technology that could solve one of the biggest problems of bone marrow transplantation: finding a donor match. Currently, a bone marrow transplant is […]

December 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Dec 2017

Novozymes and Danish Pump Producer Set Sail in Pursuit of Clean Water

As part of the company’s HelloScience initiative, Novozymes will combine its enzyme and microbial technology with Grundfos’ water pumps to provide clean water and better sanitation. Novozymes aims to improve industrial performance without harming our planet. Earlier this year, the company set up HelloScience, an online platform bringing together experts in a number of fields […]

December 4, 2017 - 2 minutesmins - By Alex Dale

News and Trends 1 Dec 2017

The Door Opens for Dutch Brain Surgery Device to Enter the Clinic

Polyganics has received €1.2M to complete the development of its dura sealant patch, which will be used to reduce the complications of brain surgery. Polyganics, based in the Groningen Medtech Hub, develops bioresorbable medical devices that aid tissue repair and regeneration. Today, the company has announced that it has received €1.2M from the European Fund for Regional […]

December 1, 2017 - 2 minutesmins - By Alex Dale

News and Trends 30 Nov 2017

Interview: Why Asian CROs are Turning to the European Biotech Market

The demand for contract research organizations (CROs) has been increasing steadily worldwide. With more and more clinical development programs being launched and a heightened demand for pharmaceutical products, companies in the biotechnology, pharmaceutical and medical technology industries are frequently deciding to outsource R&D processes to CROs. To give you an idea in numbers: In 2014, […]

November 30, 2017 - 11 minutesmins - By External Contributor

News and Trends 30 Nov 2017

Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology

Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined forces with Qiagen to develop microbiome-on-a-chip technology. Scientists around the world believe that the microbiome could hold the key to human health. One company in this area, Biomillenia, develops microbial strains from previously unculturable microbiomes to unlock its full potential. The company has now […]

November 30, 2017 - 3 minutesmins - By Alex Dale

dystrophic epidermolysis bullosa proqr rna therapy

News and Trends 30 Nov 2017

RNA Therapy for Rare Skin Disease Gets Orphan Status

The EMA has granted orphan drug designation to ProQR’s QR-313, a possible first disease-modifying treatment for the rare disease dystrophic epidermolysis bullosa. Dystrophic epidermolysis bullosa (DEB) is a genetic disease that causes the skin to easily blister, severely affecting the quality of life of patients since a very early age. Current treatment is limited to […]

November 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Nov 2017

What Exactly Happens in the Cells of People with Down’s Syndrome?

Researchers in Switzerland have taken a closer look at the cells of Down’s syndrome patients, with widespread changes in protein expression observed. Down’s syndrome, or trisomy 21, is the most common genetic disease, characterized by facial dysmorphism, learning disabilities, poor muscle tone and heart problems. Research carried out at the University of Geneva and ETH […]

November 29, 2017 - 3 minutesmins - By Alex Dale

News and Trends 29 Nov 2017

Belgian Firm Raises €80M for Rapid Infection and Cancer Tests

Biocartis is aiming to raise funds through a private placement of shares in order to support sales and further development of its rapid cancer tests. Based in Mechelen, Belgium, Biocartis focuses on developing fast, easy-to-use diagnostics. In order to boost its molecular diagnostics technology, the company launched a private equity placement of shares on Euronext […]

November 29, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 29 Nov 2017

Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer

Avelumab, marketed as Bavencio by Pfizer and Merck, has failed to show better efficacy than chemotherapy in a Phase III trial with gastric cancer patients. Merck (the German one) and Pfizer joined the checkpoint inhibitor club earlier this year with the approval of Bavencio (avelumab) in both the US and Europe. Looking to keep expanding the […]

November 29, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Nov 2017

Guilt-free and Odour-free: French Biotech Fights for Green Cosmetics

Global Bioenergies has produced the first batch of its sustainable isobutene, which L’Oréal will use to produce environmentally friendly hairspray and deodorant. Global Bioenergies has produced the first batch of its sustainable biochemical for L’Oréal. The French biotech hopes to support the shift away from fossil fuels that could change the world. It has taken its first step […]

November 29, 2017 - 3 minutesmins - By Alex Dale

News and Trends 29 Nov 2017

One Mouse with All-Human Antibodies

Monoclonal antibodies have long been the focus of research surrounding drug development against inflammatory diseases and cancer. For decades, researchers have had to travel along a strenuous path to get to where we are now. After monoclonal antibodies (mAb) were discovered in the first half of the 20th century, researchers quickly understood that animals, such […]

November 29, 2017 - 6 minutesmins - By External Contributor

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Novozymes and Danish Pump Producer Set Sail in Pursuit of Clean Water

The Door Opens for Dutch Brain Surgery Device to Enter the Clinic

Interview: Why Asian CROs are Turning to the European Biotech Market

Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology

RNA Therapy for Rare Skin Disease Gets Orphan Status

What Exactly Happens in the Cells of People with Down’s Syndrome?

Belgian Firm Raises €80M for Rapid Infection and Cancer Tests

Merck and Pfizer’s Checkpoint Inhibitor Fails to Treat Gastric Cancer

Guilt-free and Odour-free: French Biotech Fights for Green Cosmetics

One Mouse with All-Human Antibodies

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!